| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | Sep 18, 2025 | Y-mAbs Therapeutics, Inc. | COO | Sell | 42.5 | -52,100 | -100.00% | ✗ | $110.1K |
| Aug 26, 2024 | Aug 27, 2024 | Y-mAbs Therapeutics, Inc. | COO | Sell | 22.5 | -5,000 | -14.04% | ✗ | $73.5K |